Call Us: 1.800.873.5297

By

Verdicts and Settlements

Schlichter, Bogard & Denton’s aggressive approach in handling each case has produced successful settlements and verdicts in favor of our clients.  SBD has committed resources to all of our practice areas in order to acquire favorable settlements and verdicts for our clients. SBD represents hundreds of individuals injured by Vioxx® who received millions of dollars […]

By

Pharmaceutical Companies Slant Research on Defective Drugs

In attempting to assess the risks of any potentially defective drugs, diligent doctors rely not only on the drug companies or the FDA to communicate risks, but perform independent research, looking through scientific literature in their off hours to discover whether the drugs they prescribe are more helpful or harmful to their patients. Of course, some doctors […]

By

Stevens-Johnson Syndrome

Stevens-Johnson Syndrome (SJS) is a severe reaction to a medication, infection, or illness that usually requires hospitalization. The condition evolves quickly from flu-like symptoms to a skin rash, then large blisters, and eventually resulting in large patches of dead skin that blackens and falls off.  SJS is also often linked with toxic epidermal necrolysis (TEN). […]

By

Resources

The pharmaceutical injury lawyers of Schlichter, Bogard & Denton are pleased to provide information about law firms operating in other specialties to their clients throughout the United States. Philip R. Brown, Attorney at Law, is a trial attorney in Honolulu, Hawaii who practices law in many areas, including arbitrations and mediations, commercial and business, and real estate […]

By

Dangerous Drugs, Profits, and Medical Malpractice

Sometimes, no one knows about the risk a drug carries until too late. This is partly due to the FDA approval process and partly due to the inherent uncertainty in developing new drugs. Sometimes, doctors have been sold on a new drug by pharmaceutical companies so they believe the companies’ claims of safety and effectiveness. Sometimes, doctors […]

By

What to Do If Your Baby Is Hurt by a Recalled Product

If your baby is injured, it can be hard to think. You will be concerned and confused in the moment. So it is best to plan ahead for what to do if anything in the nursery turns out to be an unanticipated danger. When you are getting your nursery ready, checking to make sure you […]

By

NuvaRing® Lawsuit News

Schlichter, Bogard & Denton receives favorable ruling in NuvaRing® litigation. Click hear to read more.

By

FDA Recall & Safety Alerts

FDA Recall & Safety Alerts The Food and Drug Administration (FDA) is the government agency that monitors and regulates over-the-counter medications, prescription drugs, dietary supplements and other medical products in the United States. In an effort to provide the public with timely information on the products it monitors, the FDA releases safety alerts with information […]

By

FDA Blood Clot Warning

FDA Warns of Increased Risk of Blood Clots associated with Yaz, Yasmin, and Ocella The FDA is further reviewing the risk and expects to have results of its investigation later this summer. On May 31, 2011, the Food and Drug Administration (FDA) issued a Safety Alert directed to women who use Yaz, Yasmin, Ocella, and […]

By

Schlichter, Bogard & Denton’s Role in Yaz/Yasmin Litigation

Are you considering a lawsuit against Bayer Pharmaceuticals and Bayer Schering AG for injuries you suffered as a result of using Yaz or Yasmin birth control pills? Are you looking for the help of a law firm whose leadership on this type of litigation is recognized nationwide? Are you looking for lawyers that judges and other lawyers consider experts […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.